Neuspera Medical, headquartered in San Jose, CA, is committed to bringing forward implantable medical device technology that will improve lives of patients battling with chronic illness. The company is focused on developing products based upon its Fourth Generation Mid-Field Powering Technology, which allow for devices that are significantly smaller, implanted deeper, and more reliable than other neuromodulation technologies. This technology platform will provide patients and physicians new, and potentially earlier treatment options that are less invasive and more adaptable.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/24/18 | $26,000,000 | Series B |
6 Dimensions Capital Action Potential Venture Capital Delta Capital Delta Partners Purple Arch Ventures Windham Venture Partners | undisclosed |
